Alpine Global Management’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,400
| Closed | -$1.75K | – | 258 |
|
|
2023
Q2 | $1.75K | Sell |
15,400
-400
| -3% | -$45 | ﹤0.01% | 197 |
|
|
2023
Q1 | $632 | Sell |
15,800
-2,400
| -13% | -$96 | ﹤0.01% | 122 |
|
|
2022
Q4 | $1K | Sell |
18,200
-41,828
| -70% | -$2.3K | ﹤0.01% | 467 |
|
|
2022
Q3 | $3K | Buy |
60,028
+3,350
| +6% | +$167 | ﹤0.01% | 320 |
|
|
2022
Q2 | $5K | Buy |
56,678
+14,850
| +36% | +$1.31K | ﹤0.01% | 371 |
|
|
2022
Q1 | $15 | Buy |
41,828
+16,628
| +66% | +$6 | ﹤0.01% | 373 |
|
|
2021
Q4 | $13K | Buy |
+25,200
| New | +$13K | ﹤0.01% | 740 |
|